Depakote er and Cogentin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Depakote er (divalproex sodium) and Cogentin (benztropine mesylate). Common drug interactions include alopecia among females and diabetes mellitus among males.
The phase IV clinical study analyzes what interactions people have when they take Depakote er and Cogentin. It is created by eHealthMe based on reports of 120 people who take the same drugs from the FDA, and is updated regularly.
What is Depakote er?
Depakote er has active ingredients of divalproex sodium. It is often used in bipolar disorder. eHealthMe is studying from 6,042 Depakote er users. Check the latest studies of Depakote er.
What is Cogentin?
Cogentin has active ingredients of benztropine mesylate. It is often used in tardive dyskinesia. eHealthMe is studying from 7,692 Cogentin users. Check the latest studies of Cogentin.
120 people who take Depakote er and Cogentin together, and have interactions are studied.
What are the common drug interactions of Depakote er and Cogentin, by gender? *
What are the common drug interactions of Depakote er and Cogentin, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Depakote er and Cogentin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Depakote er (6,042 reports)
- Cogentin (7,692 reports)
Browse all drug interactions of Depakote er and Cogentin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Depakote er:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cogentin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Depakote er and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cogentin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on divalproex sodium and benztropine mesylate (the active ingredients of Depakote er and Cogentin, respectively), and Depakote er and Cogentin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Doxepin Hydrochloride and Memory Loss for Men aged 40-49 - 3 seconds ago
- Doxepin Hydrochloride and Memory Impairment for Men aged 40-49 - 4 seconds ago
- Doxepin Hydrochloride and Memory Aids for Men aged 40-49 - 4 seconds ago
- Doxepin Hydrochloride and Long-Term Memory Loss for Men aged 40-49 - 4 seconds ago
- Doxepin Hydrochloride and Sudden Memory Loss for Men aged 40-49 - 5 seconds ago
- Doxepin Hydrochloride and Temporal Memory Loss for Men aged 40-49 - 5 seconds ago
- Doxepin Hydrochloride and Loss Of Memory for Men aged 40-49 - 5 seconds ago
- Doxepin Hydrochloride and Impaired Memory for Men aged 40-49 - 6 seconds ago
- Doxepin Hydrochloride and Forgetfulness for Men aged 40-49 - 6 seconds ago
- Doxepin Hydrochloride and Amnesia for Men aged 40-49 - 6 seconds ago